from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2792c/-

LFCtreatmentdescriptionclass of inhibitor

-0.729

Amikacinug/mL Amikacintranslation

-0.302

Cap5-10ug/mL Capreomycintranslation

-0.256

Rox10-50 ug/mL Roxithromycintranslation

-0.098

SM2-5 ug/mL Streptomycintranslation

-1.237

Tet5-10 ug/mL Tetracyclinetranslation

-0.443

Rif0.2-5ug/mL Rifampicintranscription

-1.635

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.092

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.238

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.709

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.000

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.322

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.550

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.002

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.039

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

2.514

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.862

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.396

Nigericin50 uM Nigericinrespiration

-0.411

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

0.254

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.040

menadione6-10 ug/mL Menadionerespiration

-0.161

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.960

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.119

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.009

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.388

NRP_1Non-replicating persistence stage 1dosRassociated

-0.329

Amp0.2mg/mL AmpicillincellWall

-0.244

Cephalexin20-100 ug/mL CephalexincellWall

-0.392

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.664

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.452

EMB10-20 ug/mL EthambutolcellWall

-0.289

Eta12-40 ug/mL EthionamidecellWall

-0.155

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.578

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-2.032

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.087

BZA0.12 mg/mL BenzamidearomaticAmides

-0.008

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.142

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.233

H2O24 mM hydrogen peroxideDNAdamaging

3.294

Levo10 ug/mL LevofloxacinDNAdamaging

0.167

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.000

Novobiocin10 ug/mL NovobiocinDNAdamaging

4.316

Oflox5-10 ug/mL OfloxacinDNAdamaging

1.708

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.528

Antimycin12.5-50 ug/mL Antimycin A?

0.433

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.047

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.495

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.744

PA8240.2-2 ug/mL PA-824?

0.333

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.250

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.467

Verapamil50 uM Verapamil?

0.156

mercaptoethanol2 mM 2-Mercaptoethanol?

1.673

methoxatin10-20 ug/mL Methoxatin?